title: Missing data in alcohol clinical trials: a comparison of methods.
abstract: BACKGROUND
  The rate of participant attrition in alcohol clinical trials is often substantial and can cause significant issues with regard to the handling of missing data in statistical analyses of treatment effects. It is common for researchers to assume that missing data is indicative of participant relapse, and under that assumption, many researchers have relied on setting all missing values to the worst-case scenario for the outcome (e.g., missing = heavy drinking). This sort of single-imputation method has been criticized for producing biased results in other areas of clinical research, but has not been evaluated within the context of alcohol clinical trials, and many alcohol researchers continue to use the missing = heavy drinking assumption.
  
  
  METHODS
  Data from the COMBINE study, a multisite randomized clinical trial, were used to generate simulated situations of missing data under a variety of conditions and assumptions. We manipulated the sample size (n = 200, 500, and 1,000) and dropout rate (5, 10, 25, 30%) under 3 missing data assumptions (missing completely at random, missing at random, and missing not at random). We then examined the association between receiving naltrexone and heavy drinking during the first 10 weeks following treatment using 5 methods for treating missing data (complete case analysis [CCA], last observation carried forward [LOCF], missing = heavy drinking, multiple imputation [MI], and full information maximum likelihood [FIML]).
  
  
  RESULTS
  CCA, LOCF, and missing = heavy drinking produced the most biased naltrexone effect estimates and standard errors under conditions that are likely to exist in randomized clinical trials. MI and FIML produced the least biased naltrexone effect estimates and standard errors.
  
  
  CONCLUSIONS
  Assuming that missing = heavy drinking produces biased results of the treatment effect and should not be used to evaluate treatment effects in alcohol clinical trials.
authors.affiliation: Department of Psychology , University of New Mexico, Albuquerque, New Mexico.
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Hallgren
authors.forename: Katie
authors.initials: K
authors.lastname: Witkiewitz
mesh_terms: D019973:Alcohol-Related Disorders / Q000188:drug therapy*; D015982:Bias; D003625:Data Collection; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists; D010352:Patient Dropouts / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012008:Recurrence
chemical_list: D009292:Narcotic Antagonists; D009271:Naltrexone
keywords: Alcohol Use Disorder; Clinical Trials; Missing Data; Relapse; Treatment
references.citation: J Biopharm Stat. 2001 Feb-May;11(1-2):9-21
references.pmid: 11459446
references.citation: Alcohol Clin Exp Res. 2003 Jul;27(7):1107-22
references.pmid: 12878917
references.citation: JAMA. 2006 May 3;295(17):2003-17
references.pmid: 16670409
references.citation: Psychol Methods. 2001 Dec;6(4):330-51
references.pmid: 11778676
references.citation: Am J Addict. 2008 Nov-Dec;17(6):463-8
references.pmid: 19034737
references.citation: Pharm Stat. 2008 Apr-Jun;7(2):93-106
references.pmid: 17351897
references.citation: Alcohol Clin Exp Res. 2012 Aug;36(8):1421-30
references.pmid: 22324516
references.citation: Biometrics. 1989 Sep;45(3):939-55
references.pmid: 2486189
references.citation: Subst Abuse Treat Prev Policy. 2009 Feb 18;4:2
references.pmid: 19226454
references.citation: J Biopharm Stat. 2002 May;12(2):207-26
references.pmid: 12413241
references.citation: Tutor Quant Methods Psychol. 2013 Oct 12;9(2):43-60
references.pmid: 25067989
references.citation: J Biopharm Stat. 2011 May;21(3):423-36
references.pmid: 21442517
references.citation: J Stud Alcohol. 1997 Jan;58(1):7-29
references.pmid: 8979210
references.citation: Drug Alcohol Depend. 2011 Nov 1;118(2-3):493-6
references.pmid: 21549529
references.citation: Addiction. 2010 Mar;105(3):431-7
references.pmid: 20402986
references.citation: Psychol Methods. 2002 Jun;7(2):147-77
references.pmid: 12090408
references.citation: J Stud Alcohol. 1987 Mar;48(2):119-23
references.pmid: 3560947
references.citation: Annu Rev Psychol. 2009;60:549-76
references.pmid: 18652544
references.citation: Addiction. 2007 Oct;102(10):1564-73
references.pmid: 17854333
references.citation: J Subst Abuse Treat. 2009 Jul;37(1):54-63
references.pmid: 19008067
references.citation: J Stud Alcohol Suppl. 1994 Dec;12:112-8
references.pmid: 7722987
references.citation: Stat Med. 1999 Mar 30;18(6):681-94
references.pmid: 10204197
references.citation: N Engl J Med. 2012 Oct 4;367(14):1355-60
references.pmid: 23034025
references.citation: J Sch Psychol. 2010 Feb;48(1):5-37
references.pmid: 20006986
references.citation: Stat Med. 2006 Dec 30;25(24):4279-92
references.pmid: 16947139
references.citation: J Biopharm Stat. 2009;19(2):227-46
references.pmid: 19212876
references.citation: Alcohol Clin Exp Res. 2010 Dec;34(12):2022-34
references.pmid: 20659066
references.citation: Nicotine Tob Res. 2012 Sep;14(9):1100-4
references.pmid: 22180594
references.citation: Curr Med Res Opin. 2008 Jul;24(7):2001-8
references.pmid: 18534049
references.citation: J Med Internet Res. 2011 Dec 27;13(4):e117
references.pmid: 22201703
references.citation: Psychol Methods. 2011 Mar;16(1):1-16
references.pmid: 21381816
references.citation: Biostatistics. 2004 Jul;5(3):445-64
references.pmid: 15208205
references.citation: Drug Alcohol Depend. 1984 Jan;13(1):1-7
references.pmid: 6734420
references.citation: JAMA. 2007 Oct 10;298(14):1641-51
references.pmid: 17925516